R. M. Berman , M. Narasimhan , H. L. Miller , A. Anand , A. Cappiello , D. A. Oren , G. R. Heninger & D. S. Charney (1999). Transient depressive relapse induced by catecholamine depletion: potential phenotypic vulnerability marker? Archives of General Psychiatry 56, 395–403.
Z. Bhagwagar , P. J. Cowen , G. Goodwin & C. J. Harmer (2004 b). Normalization of enhanced fear recognition by acute SSRI treatment in subjects with a previous history of depression. American Journal of Psychiatry 161, 166–168.
Z. Bhagwagar , S. Hafizi & P. J. Cowen (2003). Increase in concentration of waking salivary cortisol in recovered patients with depression. American Journal of Psychiatry 160, 1890–1891.
Z. Bhagwagar , S. Hafizi & P. J. Cowen (2005). Increased salivary cortisol after waking in depression. Psychopharmacology 182, 54–57.
Z. Bhagwagar , R. Hinz , M. Taylor , S. Fancy , P. J. Cowen & P. M. Grasby (2006). Increased 5-HT2A receptor binding in euthymic, medication-free patients recovered from depression: a positron emission study with [11C]MDL 100,907. American Journal of Psychiatry 163, 1580–1587.
Z. Bhagwagar , E. A. Rabiner , P. A. Sargent , P. M. Grasby & P. J. Cowen (2004 a). Persistent reduction in brain serotonin1A receptor binding in recovered depressed men measured by positron emission tomography with [11C]WAY-100635. Molecular Psychiatry 9, 386–392.
Z. Bhagwagar , M. Wyleszinska , P. Jezzard , J. Evans , F. Ashworth , A. Sule , P. M. Matthews & P. J. Cowen (2007). Reduction in occipital cortex γ-aminobutyric acid concentrations in medication-free recovered unipolar depressed and bipolar subjects. Biological Psychiatry 61, 808–812.
J. D. Bremner , M. Vythilingam , C. K. Ng , E. Vermetten , A. Nazeer , A. Oren , R. M. Berman & D. S. Charney (2003). Regional brain metabolic correlates of α-methylparatyrosine-induced depressive symptoms: implications for the neural circuitry of depression. Journal of the American Medical Association 289, 3125–3134.
S. Campbell & G. MacQueen (2006). An update on regional brain volume differences associated with mood disorders. Current Opinion in Psychiatry 19, 25–33.
C. M. Del-Ben , J. F. W. Deakin , S. McKie , N. S. Delvai , S. R. Williams , R. Elliott , M. Dolan & I. M. Anderson (2005). The effect of citalopram pretreatment on neuronal responses to neuropsychological tasks in normal volunteers: an fMRI study. Neuropsychopharmacology 30, 1723–1734.
W. C. Drevets (2003). Neuroimaging abnormalities in the amygdala in mood disorder. Annals of the New York Academy of Sciences 985, 420–444.
W. C. Drevets , E. Frank , J. C. Price , D. J. Kupfer , D. Holt , P. J. Greer , Y. Huang , C. Gautier & C. Mathis (1999). PET imaging of serotonin 1A receptor binding in depression. Biological Psychiatry 46, 1357–1387.
P. M. Fisher , C. C. Meltzer , S. K. Ziolko , J. C. Price & A. R. Harari (2006). Capacity for 5-HT1A-mediated autoregulation predicts amygdala reactivity. Nature Neuroscience 9, 1362–1363.
C. H. Y. Fu , S. C. R. Williams , A. J. Cleare , M. J. Brammer , M. D. Walsh , J. Kim , C. M. Andrew , P. M. Williams , L. J. Reed , M. T. Mitterschiffthaler , J. Suckling & E. T. Bullmore (2004). Attenuation of the neural response to sad faces in major depression by antidepressant treatment: a prospective, event-related functional magnetic resonance imaging study. Archives of General Psychiatry 61, 877–889.
D. E. Giles , R. B. Jarrett , A. J. Rush & H. P. Roffwarg (1993). Prospective assessment of electroencephalographic sleep in remitted major depression. Psychiatry Research 46, 269–284.
I. M. Goodyer , J. Herbert , A. Tamplin & P. M. Altham (2000). Recent life events, cortisol, dehydroepiandrosterone and the onset of major depression in high-risk adolescents. British Journal of Psychiatry 177, 499–504.
S. L. Halligan , J. Herbert , I. Goodyer & L. Murray (2007). Disturbances in morning cortisol secretion in association with maternal postnatal depression predict subsequent depressive symptomatology in adolescents. Biological Psychiatry 62, 40–46.
T. O. Harris , S. Borsanyi , S. Messari , K. Stanford , S. E. Cleary , H. M. Shiers , G. W. Brown & J. Herbert (2000). Morning cortisol as a risk factor for subsequent major depressive disorder in adult women. British Journal of Psychiatry 177, 505–510.
P. J. Harrison (2002). The neuropathology of primary mood disorder. Brain 125, 1428–1449.
G. Hasler , W. C. Drevets , H. K. Manji & D. S. Charney (2004). Discovering endophenotypes for major depression. Neuropsychopharmacology 29, 1765–1781.
F. Holsboer (2000). The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology 23, 477–501.
F. Holsboer , C. J. Lauer , W. Schreiber & J.-C. Krieg (1995). Altered hypothalamic–pituitary–adrenocortical regulation in healthy subjects at high familial risk for affective disorders. Neuroendocrinology 62, 340–347.
M. Ising , C. J. Lauer , F. Holsboer & S. Modell (2005). The Munich vulnerability study on affective disorders: premorbid neuroendocrine profile of affected high-risk probands. Journal of Psychiatric Research 39, 21–28.
P. N. Johnson-Laird , F. Mancini & A. Gangemi (2006). A hyper-emotion theory of psychological illness. Psychological Reviews 113, 822–841.
K. S. Kendler , L. M. Thorton & C. O. Gardner (2001). Genetic risk, number of previous depressive episodes, and stressful life events in predicting onset of major depression. American Journal of Psychiatry 158, 582–586.
A. S. Lee & R. M. Murray (1988). The long-term outcome of Maudsley depressives. British Journal of Psychiatry 153, 741–751.
J. L. Lee , A. L. Milton & B. J. Everitt (2006). Reconsolidation and extinction of conditioned fear: inhibition and potentiation. Journal of Neuroscience 26, 10051–10056.
Z. N. Mannie , C. J. Harmer & P. J. Cowen (2007). Increased waking salivary cortisol in young people at increased familial risk of depression. American Journal of Psychiatry 164, 617–621.
S. F. B. McTavish , P. J. Cowen & T. Sharp (1996). Effect of tyrosine-free amino acid mixture on regional brain catecholamine synthesis and release. Psychopharmacology 141, 182–188.
J. Meyer , S. McMain , S. H. Kennedy , L. Korman , G. M. Brown , J. N. DaSilva & A. A. Wilson (2003). Dysfunctional attitudes and 5-HT receptors during depression and self harm. American Journal of Psychiatry 160, 60–90.
M. A. Mintun , Y. I. Sheline , S. M. Moerlein , A. G. Vlassenko , Y. Huang & A. Z. Snyder (2004). Decreased hippocampal 5-HT receptor binding in major depressive disorder: in vivo measurement with [F]altansarin positron emission tomography. Biological Psychiatry 55, 217–224.
S. Modell , M. Ising , F. Holsboer & C. J. Lauer (2005). The Munich vulnerability study on affective disorders: premorbid polysomnographic profile of affected high-risk probands. Biological Psychiatry 58, 694–699.
A. Neumeister , W. C. Drevets , I. Belfer , D. A. Luckenbaugh , S. Henry , O. Bonne , P. Herscovitch , D. Goldman & D. S. Charney (2006). Effects of α2C-adrenoreceptor gene polymorphism on neural responses to facial expressions in depression. Neuropsychopharmacology 31, 1750–1756.
A. Neumeister , A. C. Nugent , T. Waldeck , M. Geraci , M. Schwarz , O. Bonne , E. E. Bain , D. A. Luckenbaugh , P. Herscovitch , D. S. Charney & W. C. Drevets (2004). Neural and behavioral responses to tryptophan depletion in unmedicated patients with remitted major depressive disorder and controls. Archives of General Psychiatry 61, 765–773.
M. L. Phillips , W. C. Drevets , S. L. Rauch & R. Lane (2003). Neurobiology of emotion perception I: The neural basis of normal emotion perception. Biological Psychiatry 54, 504–514.
P. Piquet & M. Galvan (1994). Transient and long-lasting actions of 5-HT on rat dentate gyrus neurones in vitro. Journal of Physiology 481, 629–639.
J. C. Pruessner , O. T. Wolf , D. H. Hellhammer , A. Buske-Kirschbaum , K. von-Auer , S. Jobst & C. Kirschbaum (1997). Free cortisol levels after awakening: a reliable biological marker for the assessment of adrenocorticol activity. Life Sciences 61, 2539–2549.
S. Ramboz , R. Oosting , D. A. Amara , H. F. Kung , P. Blier , M. Mendelsohn , J. J. Mann & D. Brunner (1998). Serotonin receptor 1A knockout: an animal model of anxiety-related disorder. Proceedings of the National Academy of Sciences USA 95, 14476–14481.
H. G. Ruhé , N. S. Mason & A. H. Schene (2007). Mood is indirectly related to serotonin, norepinephrine and dopamine levels in humans: a meta-analysis of monoamine depletion studies. Molecular Psychiatry 12, 331–359.
G. Sanacora , L. R. Fenton , M. K. Fasula , D. L. Rothman , Y. Levin , J. H. Krystal & G. F. Mason (2006). Cortical γ-aminobutyric acid concentrations in depressed patients receiving cognitive behavioral therapy. Biological Psychiatry 59, 284–286.
G. Sanacora , R. Gueorguiva , C. N. Epperson , Y. T. Wu , M. Appel & D. L. Rothman (2004). Subtype-specific alterations of γ-aminobutyric acid and glutamate in patients with major depression. Archives of General Psychiatry 61, 705–713.
G. Sanacora , G. F. Mason , D. L. Rothman , F. Hyder , J. J. Ciarcia & R. B. Ostroff (2003). Increased cortical GABA concentrations in depressed patients receiving ECT. American Journal of Psychiatry 160, 577–579.
G. Sanacora , G. F. Mason , D. L. Rothman & J. H. Krystal (2002). Increased occipital cortex GABA concentrations in depressed patients after therapy with selective serotonin reuptake inhibitors. American Journal of Psychiatry 159, 663–665.
P. A. Sargent , K. A. Kjaer , C. J. Bench , E. A. Rabiner , C. Messa , J. Meyer , R. N. Gunn , P. M. Grasby & P. J. Cowen (2000). Brain serotonin (1A) receptor binding measured by positron emission tomography with [11C]WAY-100635: effects of depression and antidepressant treatment. Archives of General Psychiatry 57, 174–180.
Y. I. Sheline , D. M. Barch , J. M. Donnelly , J. M. Ollinger , A. Z. Snyder & M. A. Mintun (2001). Increased amygdala response to masked emotional faces in depressed subjects resolves with antidepressant treatment: an fMRI study. Biological Psychiatry 50, 651–658.
K. A. Smith , C. G. Fairburn & P. J. Cowen (1997). Relapse of depression after rapid depletion of tryptophan. Lancet 349, 915–919.
K. A. Smith , J. S. Morris , K. J. Friston , P. J. Cowen & R. J. Dolan (1999). Brain mechanisms associated with depressive relapse and associated cognitive impairment following acute tryptophan depletion. British Journal of Psychiatry 174, 525–529.
P. Vuillemier (2005). How brains beware: neural mechanisms of emotional attention. Trends in Cognitive Sciences 9, 585–594.
A. W. Zobel , T. Nickel , A. Sonntag , M. Uhr , F. I. Holsboer & M. Sing (2001). Cortisol response in the combined dexamethasone/CRH test as predictor of relapse in patients with remitted depression: a prospective study. Journal of Psychiatric Research 35, 83–94.